Delivery Device Patents on GLP-1 Receptor Agonists

被引：0
|
作者：
Alhiary, Rasha [1 ]
Gabriele, Sarah [1 ]
Kesselheim, Aaron S. [1 ]
Tu, S. Sean [2 ]
Feldman, William B. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA
[2] West Virginia Univ, Coll Law, Morgantown, WV USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 09期
关键词：
D O I：
10.1001/jama.2024.0919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study analyzed the US Food and Drug Administration-listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [31] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Zhao, Xin
    Wang, Minghe
    Wen, Zhitong
    Lu, Zhihong
    Cui, Lijuan
    Fu, Chao
    Xue, Huan
    Liu, Yunfeng
    Zhang, Yi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [32] GLP-1 receptor agonists and heart failure in diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2017, 43 : 2S13 - 2S19
  • [33] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [34] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [35] Two New GLP-1 Receptor Agonists for Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 109 - 111
  • [36] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [37] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Yan Xie
    Taeyoung Choi
    Ziyad Al-Aly
    Nature Medicine, 2025, 31 (3) : 951 - 962
  • [38] Why are GLP-1 receptor agonists in short supply?
    Bailey, Clifford J.
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 72 - 72
  • [39] GLP-1 Receptor Agonists in Diabetic Kidney Disease
    Michos, Erin D.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (10): : 1578 - 1580
  • [40] GLP-1 receptor agonists: differentiation within the class
    Taylor, Simeon I.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02): : 83 - 85
12345